Effects of Oral Paricalcitol on Secondary Hyperparathyroidism and Proteinuria of Kidney Transplant Patients

被引：25

作者：

Gonzalez, Esther ^{[1
]}

Rojas-Rivera, Jorge ^{[2
]}

Polanco, Natalia ^{[1
]}

Morales, Enrique ^{[1
]}

Maria Morales, Jose ^{[1
]}

Egido, Jesus ^{[2
]}

Amado, Andres ^{[1
]}

Praga, Manuel ^{[1
]}

机构：

[1] Univ Complutense Madrid, Div Nephrol, Hosp Octubre 12, Inst Invest, Madrid 28224, Spain

[2] IIS Fdn Jimenez Diaz, Div Nephrol & Hypertens, Madrid, Spain

来源：

TRANSPLANTATION | 2013年 / 95卷 / 07期

关键词：

ALBUMINURIA;

D O I：

10.1097/TP.0b013e3182855565

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：E49 / E52

页数：5

共 13 条

[1] Paricalcitol reduces albuminuria and inflammation in chronic kidney disease - A randomized double-blind pilot trial [J].

Alborzi, Pooneh ;

Patel, Nina A. ;

Peterson, Carla ;

Bills, Jennifer E. ;

Bekele, Dagim M. ;

Bunaye, Zerihun ;

Light, Robert P. ;

Agarwal, Rajiv .

HYPERTENSION, 2008, 52 (02) :249-255

[2] Significance and Management of Proteinuria in Kidney Transplant Recipients [J].

Amer, Hatem ;

Cosio, Fernando G. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (12) :2490-2492

[3] Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL [J].

de Zeeuw, D ;

Remuzzi, G ;

Parving, HH ;

Keane, WF ;

Zhang, ZX ;

Shahinfar, S ;

Snapinn, S ;

Cooper, MF ;

Mitch, WE ;

Brenner, BM .

KIDNEY INTERNATIONAL, 2004, 65 (06) :2309-2320

[4] Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial [J].

de Zeeuw, Dick ;

Agarwal, Rajiv ;

Amdahl, Michael ;

Audhya, Paul ;

Coyne, Daniel ;

Garimella, Tushar ;

Parving, Hans-Henrik ;

Pritchett, Yili ;

Remuzzi, Giuseppe ;

Ritz, Eberhard ;

Andress, Dennis .

LANCET, 2010, 376 (9752) :1543-1551

[5] Causes and consequences of proteinuria following kidney transplantation [J].

Fernandez, M. L. Suarez ;

G-Cosio, F. .

NEFROLOGIA, 2011, 31 (04) :404-414

[6] Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial [J].

Fishbane, Steven ;

Chittineni, Harini ;

Packman, Michal ;

Dutka, Paula ;

Ali, Nicole ;

Durie, Nicole .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (04) :647-652

[7]

GROTZ WH, 1995, NEPHROL DIAL TRANSPL, V10, P2096

[8] Early low-grade proteinuria: Causes, short-term evolution and long-term consequences in renal transplantation [J].

Halimi, JM ;

Laouad, I ;

Buchler, M ;

Al-Najjar, A ;

Chatelet, V ;

Houssaini, TS ;

Nivet, H ;

Lebranchu, Y .

AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (09) :2281-2288

[9] Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease [J].

Jafar, TH ;

Stark, PC ;

Schmid, CH ;

Landa, M ;

Maschio, G ;

Marcantoni, C ;

de Jong, PE ;

de Zeeuw, D ;

Shahinfar, S ;

Ruggenenti, P ;

Remuzzi, G ;

Levey, AS .

KIDNEY INTERNATIONAL, 2001, 60 (03) :1131-1140

[10] Paricalcitol attenuates cyclosporine-induced kidney injury in rats [J].

Park, Jeong Woo ;

Bae, Eun Hui ;

Kim, In Jin ;

Ma, Seong Kwon ;

Choi, Chan ;

Lee, JongUn ;

Kim, Soo Wan .

KIDNEY INTERNATIONAL, 2010, 77 (12) :1076-1085

← 1 2 →